Capricor Therapeutics
Latest round
- Series A
Last raised
- Dec 2010
Total raised
- $2M
Investors
- 1
About Capricor Therapeutics
Capricor Therapeutics, Inc.Founded in 2005 in Beverly Hills, US, Capricor Therapeutics, Inc. specializes in developing biopharmaceutical products.S. Department of Defense in September 2016.2 mn.Capricor Therapeutics, Inc. specializes in innovative biopharmaceutical products aimed at treating Duchenne muscular dystrophy (DMD) and a variety of other severe diseases through advanced cell and exosome-based therapies. Their core offerings include allogeneic cardiosphere-derived cells (CDCs) and exosome science, which are utilized to create novel therapeutic approaches that address critical unmet medical needs. The company's pipeline encompasses multiple stages of development, focusing on precision medicine tailored to individual patient profiles.18 mn.01 mn during the same year.S. Department of Defense to support the development of new products aimed at treating severe diseases. The company is focused on expanding its market presence into new geographic regions, including North America and Europe, by 2024. Additionally, Capricor is actively working on advancing its pipeline of exosome-based therapeutics, which are designed to meet critical health needs, with ongoing clinical trials to evaluate their efficacy.
Who invested in Capricor Therapeutics
1 investor across 1 round
See all investors in Capricor Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 20, 2010
Amount
$2M
Investors
Questions about Capricor Therapeutics
Who invested in Capricor Therapeutics?
Capricor Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Capricor Therapeutics raised?
Capricor Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Capricor Therapeutics last raise money?
Capricor Therapeutics's most recent round on record is a Series A, in Dec 2010.
What does Capricor Therapeutics do?
Capricor Therapeutics is a biotechnology company.
Where is Capricor Therapeutics headquartered?
Capricor Therapeutics is headquartered in Beverly Hills, US.
Which VCs invest in companies like Capricor Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Capricor Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Capricor Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.